Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination
- 15 April 2022
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 130 (8), 1187-1203
- https://doi.org/10.1161/circresaha.122.319954
Abstract
The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has been extensively reported since the onset of the pandemic. The striking efforts of many scientists in cooperation with regulators and governments worldwide have rapidly brought the development of a large landscape of vaccines against SARS-CoV-2. The novel DNA and mRNA vaccines have offered great flexibility in terms of antigen production and led to an unprecedented rapidity in effective and safe vaccine production. However, as mass vaccination has progressed, rare but catastrophic cases of thrombosis have occurred in association with thrombocytopenia and antibodies against PF4 (platelet factor 4). This catastrophic syndrome has been named vaccine-induced immune thrombotic thrombocytopenia. Rarely, ischemic stroke can be the symptom onset of vaccine-induced immune thrombotic thrombocytopenia or can complicate the course of the disease. In this review, we provide an overview of stroke and cerebrovascular disease as a complication of the SARS-CoV-2 infection and outline the main clinical and radiological characteristics of cerebrovascular complications of vaccinations, with a focus on vaccine-induced immune thrombotic thrombocytopenia. Based on the available data from the literature and from our experience, we propose a therapeutic protocol to manage this challenging condition. Finally, we highlight the overlapping pathophysiologic mechanisms of SARS-CoV-2 infection and vaccination leading to thrombosis.Keywords
This publication has 122 references indexed in Scilit:
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorNature, 2020
- Association Between Left Ventricular Ejection Fraction, Wall Motion Abnormality, and Embolic Stroke of Undetermined SourceJournal of the American Heart Association, 2019
- Risk Factors for Stroke in Patients With Sepsis and Bloodstream InfectionsStroke, 2019
- Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanismsBlood, 2019
- Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2PLoS Pathogens, 2018
- Relationship Between Visceral Infarction and Ischemic Stroke SubtypeStroke, 2018
- Autoimmune heparin‐induced thrombocytopeniaJournal of Thrombosis and Haemostasis, 2017
- Embolic Stroke of Undetermined SourceStroke, 2017
- Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosisThrombosis Research, 2014
- Duration of atrial fibrillation and imminence of stroke: the Framingham study.Stroke, 1983